Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: Validation of a simplified method suitable for multi-center clinical studies

Leukemia Research

Volumn 34, Issue 6, 2010, Pages 809-815

  Hayes, Gregory M ^a   Busch, Robert ^a,d   Voogt, Jason ^a   Siah, Iche M ^a   Gee, Tracy A ^a   Hellerstein, Marc K ^b   Chiorazzi, Nicholas ^c   Rai, Kanti R ^c   Murphy, Elizabeth J ^a,e  

^a KINEMED INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell isolation; Cell proliferation; CLL

Indexed keywords

CD5 ANTIGEN; DEUTERIUM OXIDE; DNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL ISOLATION; CELL LABELING; CELL PROLIFERATION; CELL SELECTION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKEMIA CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MULTICENTER STUDY; PRIORITY JOURNAL; VALIDATION PROCESS;

ADULT; AGED; B-LYMPHOCYTES; BLOOD SPECIMEN COLLECTION; BONE MARROW CELLS; CELL PROLIFERATION; CELL SEPARATION; CLINICAL TRIALS AS TOPIC; CYTODIAGNOSIS; DEUTERIUM OXIDE; DNA; EFFICIENCY; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC;

EID: 77952090367     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.09.032     Document Type: Article

References (10)

1. Chiorazzi N. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract Res Clin Haematol 2007, 20(September (3)):399-413.
2. Busch R., Neese R.A., Awada M., Hayes G.M., Hellerstein M.K. Measurement of cell proliferation by heavy water labeling. Nat Protoc 2007, 2(12):3045-3057.
3. Messmer B.T., Messmer D., Allen S.L., Kolitz J.E., Kudalkar P., Cesar D., et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005, 115(March (3)):755-764.
4. Defoiche J., Debacq C., Asquith B., Zhang Y., Burny A., Bron D., et al. Reduction of B cell turnover in chronic lymphocytic leukaemia. Br J Haematol 2008, 143(October (2)):240-247.
5. van Gent R., Kater A.P., Otto S.A., Jaspers A., Borghans J.A., Vrisekoop N., et al. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. Cancer Res 2008, 68(December (24)):10137-10144.
6. Voogt J.N., Awada M., Murphy E.J., Hayes G.M., Busch R., Hellerstein M.K. Measurement of very low rates of cell proliferation by heavy water labeling of DNA and gas chromatography/pyrolysis/isotope ratio-mass spectrometric analysis. Nat Protoc 2007, 2(12):3058-3062.
7. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996, 87(June (12)):4990-4997.
8. Busch R., Cesar D., Higuera-Alhino D., Gee T., Hellerstein M.K., McCune J.M. Isolation of peripheral blood CD4(+) T cells using RosetteSep and MACS for studies of DNA turnover by deuterium labeling. J Immunol Methods 2004, 286(March (1-2)):97-109.
9. Chen J.L., Peacock E., Samady W., Turner S.M., Neese R.A., Hellerstein M.K., et al. Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis. J Biol Chem 2005, 280(July (27)):25396-25402.
10. 2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci USA 2002, 99(November (24)):15345-15350.